drugset / Trial / NCT03212352

Comparing Two Medical Treatments for Early Pregnancy Failure.

NCT03212352

RandomizedParallel-groupDouble-blindTreatment

Summary

This study aims to compare whether a combination of two drugs (Mifepristone and misoprostol) are superior compared to using only one of these drugs (Misoprostol) as medical treatment for a miscarriage. Women in whom early pregnancy failure, 6-14 weeks postmenstrual, is ultrasonographically confirmed qualify for this study. It is expected that the combination of Mifepristone and Misoprostol is more effective in reaching complete evacuation, and therefore can prevent more invasive treatment such as curettage.

Timeline

Start
2018-06-27
Primary completion
2020-01-23
Completion
2020-03-16

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Mifepristone Small molecule 600 mg Oral
Background Misoprostol Other / unclassified 800 ug Oral